Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia.

Authors:
Liao Z; Xu L; Wan B; Wang L; Zhao C and 2 more

Journal:
Emerg Med Int

Publication Year: 2022

DOI:
10.1155/2022/1177946

PMCID:
PMC9578913

PMID:
36267140

Journal Information

Full Title: Emerg Med Int

Abbreviation: Emerg Med Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Emergency Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure Zhimin Liao and Lei Xu are the cofirst authors. Conflicts of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025